More than 40 mutations in the Tau-encoding MAPT locus have been identified as a direct cause for FTDP-17, and slightly higher expression of Tau driven by the Tau H1 haplotype increases risk for AD and PD4, 5, 6. The gene discussed is MAPT; the disease is Alzheimer disease.